Loading…
bioMérieux, a global player in in-vitro diagnostics and food microbiology testing, acquired Invisible Sentinel Inc., a Philadelphia-based developer of molecular diagnostic tools for food and beverage pathogen detection. The acquisition strengthens bioMérieux's position in food pathogen testing and spoilage organism detection.
BioMérieux acquired Astute Medical, developer of the NephroCheck test, for approximately $90 million.
BioFire Diagnostics, a subsidiary of bioMérieux, opened the Alain Mérieux Center for Molecular Diagnostics in Salt Lake City, Utah, on May 17, 2017. The facility is a new center for molecular diagnostics, dedicated to the company's founder.